Does CBD really work?

UC experts join WVXU's Cincinnati Edition

As recreational marijuana sales are coming to Ohio, more CBD shops are springing up in the meantime selling a variety of tinctures, topicals and tonics with various claims of health benefits. CBD is claimed to relieve pain, anxiety, insomnia and more, but what does the research say?

The University of Cincinnati's LaTrice Montgomery, PhD, and Michael Privitera, MD, joined WVXU's Cincinnati Edition to discuss how CBD claims stack up to scientific research.

Privitera said Epidiolex, a CBD medication for epilepsy, is currently the only Food and Drug Administration approved CBD treatment. Epidiolex contains more than 10 to 20 times the CBD concentration of products that can be purchased in health food stores or gas stations. 

"There’s a lot of other information out there, but...the FDA has not approved CBD for anything other than epilepsy," said Privitera, professor and division chief for epilepsy in UC's Department of Neurology and Rehabilitation Medicine in UC's College of Medicine and director of the UC Gardner Neuroscience Institute Epilepsy Center. "If you look at for example medical marijuana laws in the state of Ohio, there’s lots of conditions...But there’s not been good randomized clinical trial data about most of the indications including pain, anxiety and sleep." 

Montgomery said in Ohio, hemp products are certified by the Ohio Department of Agriculture, but it is not strictly regulated. Studies have found the actual concentration of CBD in consumer products can vary widely compared to what is on its label.

"So it may suggest there’s a low level of THC in hemp products when actually there might be higher levels, and vice versa," said Montgomery, adjunct associate professor in the Department of Psychiatry and Behavioral Neuroscience in UC's College of Medicine and a licensed clinical psychologist. "So it’s not very well regulated." 

Listen to the Cincinnati Edition segment.

Featured photo at top of CBD oil. Photo/CBD Infos/Unsplash.

Related Stories

1

Dealing with seasonal affective disorder

November 18, 2026

Fewer daylight hours can make it more difficult for those who experience seasonal affective disorder. Cincinnati Edition on 91.7 WVXU News/Cincinnati Public Radio recently discussed ways to monitor mental health as the days grow shorter. Ann Romaker, MD, of the University of Cincinnati College of Medicine, a professor of clinical medicine in the Division of Pulmonary, Critical Care and Sleep Medicine within the Department of Internal Medicine and the medical director of UC Health's Sleep Medicine program, joined the discussion.

2

Have COVID-19 vaccines become a distant memory?

November 18, 2026

A University of Cincinnati infectious diseases expert warns that this could be a brutal season for COVID-19, the flu and RSV. New research also suggests that repeated COVID-19 infections increase a person's risk of long COVID. Carl Fichtenbaum, MD, professor of clinical medicine and vice chair for clinical research in the College of Medicine's Department of Internal Medicine, recently joined Cincinnati Edition on 91.7 WVXU News to discuss vaccination.

3

New guidance targets dangerous ‘rhino tranq’ withdrawal

November 18, 2026

The University of Cincinnati's M. Ross Lawson and Richard Ryan spoke with Medscape about new American Society of Addiction Medicine clinical guidance on managing intoxication and potentially life-threatening complications from withdrawal associated with medetomidine, also known as “rhino tranq.”